Literature DB >> 20232782

Safety of a 2-visit cluster schedule of venom immunotherapy in outpatients at risk of life-threatening anaphylaxis.

I Sánchez-Machín1, C Moreno, R González, J Iglesias-Souto, E Pérez, V Matheu.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20232782

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  4 in total

Review 1.  Venom immunotherapy: an updated review.

Authors:  Darío Antolín-Amérigo; Carmen Moreno Aguilar; Arantza Vega; Melchor Alvarez-Mon
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

Review 2.  Risk associated with bee venom therapy: a systematic review and meta-analysis.

Authors:  Jeong Hwan Park; Bo Kyung Yim; Jun-Hwan Lee; Sanghun Lee; Tae-Hun Kim
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

3.  Venom allergy treatment practices in Poland in comparison to guidelines: next edition of the national audit.

Authors:  Ewa Cichocka-Jarosz; Marcin Stobiecki; Marita Nittner-Marszalska; Urszula Jedynak-Wąsowicz; Piotr Brzyski
Journal:  Postepy Dermatol Alergol       Date:  2019-06-19       Impact factor: 1.837

Review 4.  Venom immunotherapy for preventing allergic reactions to insect stings.

Authors:  Robert J Boyle; Mariam Elremeli; Juliet Hockenhull; Mary Gemma Cherry; Max K Bulsara; Michael Daniels; J N G Oude Elberink
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.